المساهمون: Okita, Kiwamu., Yamaguchi Symposium on Liver Disease (1999), Yamaguchi Symposium on Liver Disease (11th : 1999)

مصطلحات موضوعية: Liver Neoplasms -- etiology., Liver Cirrhosis -- therapy., Hepatitis, Chronic -- therapy., Liver Cirrhosis -- complications., Liver Cirrhosis -- complications, Hepatitis, Chronic -- therapy, Liver Cirrhosis -- therapy, Liver Neoplasms -- etiology, Liver -- Cirrhosis -- Congresses., Chronic active hepatitis -- Congresses., Congresses., Conference proceedings., Yamaguchi (1999), Conference papers and proceedings.

المساهمون: Bosch, Jaime., Falk Foundation.

مصطلحات موضوعية: Liver Cirrhosis -- therapy., Liver Cirrhosis -- etiology., Liver -- Cirrhosis -- Congresses., Congresses., Conference papers and proceedings., Falk, Disease management

Relation: Falk Symposium (162nd : 2007 : Dresden, Germany)

المؤلفون: COUTO, Cláudia Alves, TERRABUIO, Debora Raquel Benedita, CANÇADO, Eduardo Luiz Rachid, PORTA, Gilda, LEVY, Cynthia, SILVA, Antônio Eduardo Benedito, BITTENCOURT, Paulo Lisboa, CARVALHO FILHO, Roberto José de, CHAVES, Dalton Marques, MIURA, Irene Kazue, CODES, Liana, FARIA, Luciana Costa, EVANGELISTA, Andreia Silva, FARIAS, Alberto Queiroz, GONÇALVES, Luciana Lofêgo, HARRIZ, Michelle, LOPES, Edmundo Pessoa de Almeida, LUZ, Gustavo Oliveira, OLIVEIRA, Patrícia Marinho Costa, OLIVEIRA, Elze Maria Gomes, SCHIAVON, Janaina Luz Narciso, SEVÁ-PEREIRA, Tiago

المصدر: Arquivos de Gastroenterologia. June 2019 56(2)

مصطلحات موضوعية: Autoimmune hepatitis, diagnosis, Autoimmune hepatitis, therapy, Sclerosing cholangitis, diagnosis, Sclerosing cholangitis, therapy, Biliary liver cirrhosis, diagnosis, Biliary liver cirrhosis, therapy, Medical societies

وصف الملف: text/html

URL الوصول: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032019000200232

المؤلفون: Harr Freeya Njai, Ramou Njie, Gibril Ndow, Aboubacar Kambi, Maimuna Mendy, Isabelle Chemin, Tumani Corrah, Saydiba Tamba, Maud Lemoine, Adam Jeng, Louise Sarr, Souleymane Mboup, Shevanthi Nayagam, Mark Thursz, Hilton Whittle, Jessica Howell, Penda Suso, Makie Taal, Amina Sow, Liliane Mpabanzi, Simon D. Taylor-Robinson, Yusuke Shimakawa, Ousman Nyan, William Stanger, Coumba Toure-Kane, Saunab Ghosh, Abdullah Jatta, Umberto D'Alessandro

المساهمون: Medical Research Council Unit The Gambia (MRC), St Mary's Hospital [London], Epidémiologie des Maladies Emergentes - Emerging Diseases Epidemiology, Pasteur-Cnam Risques infectieux et émergents (PACRI), Institut Pasteur [Paris]-Conservatoire National des Arts et Métiers [CNAM] (CNAM)-Institut Pasteur [Paris]-Conservatoire National des Arts et Métiers [CNAM] (CNAM), Centre International de Recherche contre le Cancer - International Agency for Research on Cancer (CIRC - IARC), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Ministry of Health and Social Welfare [Banjul, The Gambia] (MOHSW), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hôpital Aristide-Le-Dantec, School of Nutrition and Translational Research in Metabolism [Maastricht] (NUTRIM), Maastricht University [Maastricht], Royal Free Hospital [London, UK], Edward Francis Small Teaching Hospital [Banjul, Gambia] (EFSTH), London School of Hygiene and Tropical Medicine (LSHTM), We thank the European Commission for funding the programme, Gilead Sciences (USA) for providing tenofovir treatment for the patients, the MRC laboratories The Gambia unit, the local Ministry of Health and Social Welfare, and the National Public Health Laboratories for supporting the project, We also thank the French Research Agency on HIV/AIDS and viral hepatitis (ANRS) for supporting ML's work within the PROLIFICA project. We also acknowledge the support of the UK Medical Research Council and the UK Department for International Development who jointly funded (under the MRC/DFID Concordat agreement) the clinical research fellowship that supports SN. We acknowledge the support of the UK National Institute for Health Research Biomedical Research Centre at Imperial College London for infrastructure support., We thank all study participants and the PROLIFICA team, in particular Ignatius Baldeh, Famara Bojang, Amie Ceesay, Mavis Foster-Nyarko, Debbo Jallow, Sheriff Kolley, Yamundow Jallow Samba, Alagie Sanneh, Bakary Sanneh, Demba Sonko, Lamin Bojang, and Mamina Bojang. We thank Mariama Jammeh, the coordinator of the national blood bank programme, Debbie Garside, the project manager of PROLIFICA, Christian Bottomley for statistical advice, and Alexandra Davis for drafting the study map. We thank Mary Crofton and Patrick Ingiliz for their clinical contributions., We are grateful to our dear colleague Dr Harr Njai, who died before the study could be published. We miss her warm and radiant personality., Institut Pasteur [Paris] (IP)-Conservatoire National des Arts et Métiers [CNAM] (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-Institut Pasteur [Paris] (IP)-Conservatoire National des Arts et Métiers [CNAM] (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM), Gilead Sciences Inc, Imperial College Trust, Commission of the European Communities, Wellcome Trust, Imperial College Healthcare NHS Trust- BRC Funding, Medical Research Council (MRC), Shimakawa, Yusuke

المصدر: The Lancet global health
The Lancet global health, Elsevier, 2016, 4 (8), pp.e559-e567. ⟨10.1016/S2214-109X(16)30130-9⟩
The Lancet Global Health, Vol 4, Iss 8, Pp e559-e567 (2016)
The Lancet global health, 2016, 4 (8), pp.e559-e567. ⟨10.1016/S2214-109X(16)30130-9⟩
e567
e559

مصطلحات موضوعية: Liver Cirrhosis, Male, HBsAg, Blood Donors, medicine.disease_cause, Liver disease, MESH: Hepatitis B virus / immunology, 0302 clinical medicine, Epidemiology, Prevalence, EPIDEMIOLOGY, CRITERIA, Mass Screening, 030212 general & internal medicine, PROTECTION, MESH: Liver Cirrhosis / therapy, SUB-SAHARAN AFRICA, Public, Environmental & Occupational Health, 2. Zero hunger, MESH: Middle Aged, lcsh:Public aspects of medicine, Age Factors, General Medicine, Hepatitis B, Middle Aged, MESH: Mass Screening / methods, MESH: Liver Cirrhosis / diagnosis, 3. Good health, COMMUNITY, PROLIFICA investigators, MESH: Hepatitis B Surface Antigens / blood, CARRIAGE, MESH: Hepatitis B / diagnosis, MESH: Point-of-Care Systems, VACCINATION, 030211 gastroenterology & hepatology, Female, Gambia, MESH: Hepatitis B / epidemiology, Life Sciences & Biomedicine, 0605 Microbiology, Adult, MESH: Antiviral Agents, medicine.medical_specialty, Hepatitis B virus, MESH: Gambia / epidemiology, Point-of-Care Systems, Antiviral Agents, Communicable Diseases, 1117 Public Health and Health Services, 03 medical and health sciences, Sex Factors, MESH: Sex Factors, Internal medicine, medicine, Humans, Disease burden, Mass screening, MESH: Prevalence, MESH: Age Factors, Science & Technology, Hepatitis B Surface Antigens, MESH: Humans, business.industry, MESH: Blood Donors, lcsh:RA1-1270, MESH: Adult, Odds ratio, CARE, medicine.disease, MESH: Male, MESH: Communicable Diseases, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, SETTINGS, Immunology, Feasibility Studies, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, business, MESH: Feasibility Studies, MESH: Female

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ce96b12b42eac91dfb0ac53ad6b8113
https://hal-pasteur.archives-ouvertes.fr/pasteur-02875279/file/1-s2.0-S2214109X16301309-main.pdf

المصدر: Nederlands Tijdschrift voor Geneeskunde. 141(15):719-723

مصطلحات موضوعية: Fluid Therapy/methods, Pulmonary Edema/therapy, Nephrotic Syndrome/therapy, Osmotic Pressure, Liver Cirrhosis/therapy, Humans, Colloids, Plasmapheresis, Plasma Substitutes/therapeutic use, Serum Albumin/deficiency

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dris___00893::789af1ea3a0b4999254b56d880c1ee58
https://www.ntvg.nl/artikelen/klinische-toepassing-van-albumine-indicaties-nader-bekeken/ingezonden-mededelingen

المؤلفون: Vesna Degoricija, Siniša Šefer, Vanja Zjačić-Rotkvić, Branko Troskot, Božidar Vrhovac, Suzana Anić

المصدر: Acta clinica Croatica
Volume 42
Issue 2

مصطلحات موضوعية: Jetrena ciroza, liječenje, Jetrena ciroza, komplikacije, Ascites, etiologija, Ascites, prevencija i suzbijanje, Anketa, Prikupljanje podataka, Liver cirrhosis, therapy, Liver cirrhosis, complications, Ascites, etiology, Ascites, prevention and control, Questionnaires, Data collection

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od_______951::4aa0434d4ec97eeff72ea621ba935efe
https://hrcak.srce.hr/14591

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.